Health Care & Life Sciences » Pharmaceuticals | Choong Ang Vaccine Laboratory

Choong Ang Vaccine Laboratory | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
4,450
4,284
3,254
6,209
4,579
Depreciation, Depletion & Amortization
3,402
3,078
3,644
2,988
3,429
Other Funds
488
664
89
1,598
450
Funds from Operations
8,340
8,027
6,987
10,795
8,458
Changes in Working Capital
4,402
1,357
2,943
3,085
896
Net Operating Cash Flow
3,938
6,670
9,930
7,710
7,562
Capital Expenditures
6,576
4,243
3,044
7,219
13,588
Sale of Fixed Assets & Businesses
-
11
23
8
-
Purchase/Sale of Investments
2,875
697
1,851
100
114
Net Investing Cash Flow
3,690
1,468
4,887
7,974
13,474
Cash Dividends Paid - Total
366
366
366
366
366
Issuance/Reduction of Debt, Net
491
351
3,100
6,189
1,909
Net Financing Cash Flow
125
15
3,466
5,823
1,543
Net Change in Cash
363
5,085
1,381
5,677
4,517
Free Cash Flow
1,779
3,324
7,332
1,147
5,617
Other Sources
-
2,056
-
-
-
Exchange Rate Effect
10
103
196
117
148
Other Uses
-
-
-
656
-

About Choong Ang Vaccine Laboratory

View Profile
Address
1476-37 Yuseong-daero
Daejeon DE 34055
Korea, Republic Of
Employees -
Website http://www.cavac.co.kr
Updated 09/14/2018
Choong Ang Vaccine Laboratory Co., Ltd. engages in the provision of animal health solutions and biologicals. Its main products include vaccines for swine, poultry, dog, cattle, cat, rabbit, and fish, rapid diagnostic kits and, diagnostic kits. The company was founded on December 6, 1968 and is headquartered in Daejeon, South Korea.